Dental infection treatment companies are committed to developing effective solutions for oral health challenges, particularly in treating infections. Through research and product development, these companies offer advanced therapies, medications, and dental care products to combat and prevent infections, ensuring optimal oral well-being.
Intuit Therapeutics receives FDA Fast Track designation for its ITI-2121, a novel biotherapeutic candidate for the treatment of gum disease. This signifies a shift towards targeted therapies aiming to address the underlying inflammation in dental infections.
Cellectis and MabVax Therapeutics partner to develop CAR-T cell therapy for treating oral squamous cell carcinoma, a potentially fatal dental infection-related cancer. This collaboration represents a groundbreaking approach in using personalized immunotherapy for aggressive dental infections.
Align Technology, the maker of Invisalign clear aligners, announces the acquisition of exocad, a leading dental software company. This move strengthens Align's position in digital dentistry and paves the way for integration of AI and robotics in dental infection treatment.
DentalEZ introduces the Intego Pro X-ray system with AI-powered image analysis. This innovation assists dentists in faster and more accurate diagnosis of dental infections through automated caries and periodontal disease detection.
List of Dental Infection Treatment Key Companies in the Market
Dental Infection Treatment Market Highlights:
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)